About Florida Cancer Specialists & Research Institute, LLC: (Homepage)
Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Celebrating its 40th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
Florida Cancer Specialists & Research Institute, in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has been granted a 3-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.
Read More
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer
January 5th 2024Bradley J. Monk, MD, FACS, FACOG, discusses the enrollment criteria and dosing for the phase 3 KEYNOTE-A18 study of patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer.
Watch
The Florida Cancer Specialists & Research Institute, LLC 2022 Annual Report, produced by the FCS in-house Marketing team, has been recognized in the 4th Annual Healthcare Digital Marketing Awards, a prestigious national awards program that recognizes excellence in healthcare and medical marketing.
Read More
Florida Cancer Specialists & Research Institute Physicians Recognized for Expertise in 2023
January 2nd 2024Florida Cancer Specialists & Research Institute physicians were recognized in 2023 by their physician peers, patients and residents as top doctors in their local communities for providing world-class treatment for all forms of cancers and blood disorders.
Read More
Maen Hussein: ‘Every Success Motivates Us to Do Even Better’
November 16th 2023In an interview with Targeted Oncology, Maen Hussein, MD, a Q3 2023 Oncology Icons honoree, discusses his path to the community oncology setting and highlights upcoming trends in oncology he feels will improve patient outcomes.
Read More
Emergency Preparedness in Florida Essential for All Oncology Practices
November 11th 2023In an interview with Peers & Perspectives in Oncology, Barbara Morris, DHSc, LAT, ATC, CSCS, HDDP, the director of corporate safety at Florida Cancer Specialists and Research Institute (FCS), discussed how her organization prepares for hurricanes, so that patients and employees remain safe and up-to-date throughout the storm.
Read More